FIELD: pharmacology.
SUBSTANCE: invention relates to an inhibitor of 17α-hyroxilase-17,20-lyase (CYP17A1) activity, inhibiting the growth of prostate cancer cells, which is a derivative of pregn-17(20)-ene of the general formula 
(I), where R is 4',5'-dihydro-1',3'-oxazole-2'-yl- 
(Ia), or benzo-[d]-oxazole-2'-yl 
(Ib).
EFFECT: CYP17A1 activity inhibitor of general formula I can be used for prostate cancer treatment.
1 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUMOUR AGENT FOR TREATING PROSTATE CANCER IN THE FORM OF SACHET | 2018 |
|
RU2695326C1 |
| PHOSPHORYL SUBSTITUTED 3-KETO-ANDROST-4-ENE-[16,17-D]PYRIDAZINES AND METHOD OF THEIR PREPARATION | 2023 |
|
RU2807870C1 |
| TROPONE-SUBSTITUTED PHENYLOXAZOLIDINONE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR HYDRATES | 1993 |
|
RU2119484C1 |
| NOVEL AMINO ACID DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2747673C2 |
| SUBSTITUTED AZACYLS AS TRPM8 MODULATORS | 2020 |
|
RU2839995C1 |
| 4-HETERO-16α, 17α-CYCLOHEXANOPREGNANES | 2009 |
|
RU2426737C1 |
| CYCLIC N,N'-DIARYLTHIOUREAS OR N,N'-DIARYLUREAS - ANTAGONISTS OF ANDROGEN RECEPTORS, ANTI-CANCER MEDICATION, METHOD OF OBTAINING AND APPLICATION | 2010 |
|
RU2434851C1 |
| METHOD OF PRODUCING 17-(3-HYDROXYPROPYL)-17-HYDROXYSTEROIDS | 2008 |
|
RU2466137C2 |
| SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
| SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
